Natco Pharma Limited Apixaban Export Data — India (DGFT 2022–2026)

Name: Natco Pharma Limited Apixaban Export Records India — #6 Exporter, 72 Shipments, $3.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Apixaban

India Pharmaceutical Trade Intelligence

$179.9M171 Suppliers98 CountriesHS 30049099

ExportsIndia → LEBANON41.8%India → CANADA18.3%

ImportsGERMANY → India$14.0B BELGIUM → India$17.4M

Natco Pharma Limited — Apixaban Exporter #6 | $3.6M Trade Value | TransData Nexus | TransData Nexus

Natco Pharma Limited — Apixaban Exporter Profile

Indian Pharmaceutical Exporter · #6 for Apixaban · $3.6M export value · DGFT Verified

Natco Pharma Limited is the #6 Indian exporter of Apixaban with $3.6M in export value and 72 verified shipments. Natco Pharma Limited holds a 2.0% market share in Apixaban exports across 7 countries. The company exports 17 pharmaceutical products worth $36.0M across 6 therapeutic categories.

Natco Pharma Limited — Apixaban Export Profile: Buyers & Destinations

Natco Pharma Limited Apixaban export treemap — buyers and destination countries | TransData Nexus

Where Does Natco Pharma Limited Export Apixaban?

Country	Value	Shipments	Share
BRAZIL	$932.4K	19	42.3%
CANADA	$523.1K	18	23.7%
MYANMAR	$386.9K	11	17.6%
PHILIPPINES	$150.5K	10	6.8%

Who Are the Top Buyers of Apixaban from Natco Pharma Limited?

Buyer	Country	Value	Orders
NATCOFARMA DO BRASIL LTDA	BRAZIL	$582.4K	12
ABC INTERNATIONAL LTD	MYANMAR	$386.9K	11
NATCO PHARMA (CANADA) INC	CANADA	$332.1K	14
NATCOFARMA DO BRASIL LTDA,	BRAZIL	$300.0K	6
NATCO PHARMA (CANADA)INC	CANADA	$141.3K	3
NATCO LIFESCIENCES PHILIPPINES INC	PHILIPPINES	$81.4K	7
NATCO LIFESCIENCES PHILIPPINES INC,	PHILIPPINES	$69.1K	3
BOSTON ONCOLOGY ARABIA	SAUDI ARABIA	$68.0K	5
NATCOFARMA DO BRASIL LIMITED A AV QUINHENTOS N	BRAZIL	$50.0K	1
ABC INTERNATIONAL LIMITED	THAILAND	$50.0K	1

Natco Pharma Limited supplies Apixaban to 15 buyers globally. The largest buyer is NATCOFARMA DO BRASIL LTDA (BRAZIL), followed by ABC INTERNATIONAL LTD (MYANMAR) and NATCO PHARMA (CANADA) INC (CANADA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Apixaban Formulations Does Natco Pharma Limited Export?

Product Description / Formulation	Value	Shipments
APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R	$150.0K	3
APIXABAN 2.5MG TABLETS 20'S (APPENDIX 4R	$132.4K	3
NAT-APIXABAN 2.5 MG TABLETS 60'S(23580X60'S) (APPENDIX 4R, RODTEP ENTRY NO:10153)(OTHER REFERENCE(S) CI NO:124023)	$129.2K	3
APIXABAN 5MG TABLETS 60'S (APPENDIX 4R,	$100.0K	2
APIXABAN 5MG TABLETS 20'S (APPENDIX 4R,	$100.0K	2
NAT-APIXABAN 5MG TABLETS 60'S (9120X60'S)(APPENDIX 4R, RODTEP ENTRY NO:10153)(OTHER REFERENCE(S)CI NO:123238)NOS	$61.9K	3
APIXABAN 2.5MG TABLETS 60'S (OTHER REFER	$58.2K	2
APIXABAN 2.5MG TABLES 30'S (26444X30'S )(ALONG WITH 2646 BLISTERS OF FREE SAMPLES)NOS	$58.2K	3
NAT-APIXABAN 2.5MG TABLETS 60'S (OTHER R	$50.0K	1
NAT-APIXABAN 5MG TABLETS 180'S (OTHER RE	$50.0K	1

Natco Pharma Limited exports 49 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is APIXABAN 2.5MG TABLETS 60'S (APPENDIX 4R with 3 shipments worth $150.0K.

How Does Natco Pharma Limited Compare to Nearest Apixaban Exporters?

Exporters ranked immediately above and below #6 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MACLEODS PHARMACEUTICALS LTD	$4.3M	85	9	$50.0K
8	UNISON PHARMACEUTICALS PRIVATE LIMITED	$3.9M	114	5	$34.2K
6	NATCO PHARMA LIMITED ★	$3.6M	72	7	$50.0K
7	MICRO LABS LIMITED	$3.4M	68	14	$50.0K
9	EMCURE PHARMACEUTICALS LIMITED	$3.0M	122	2	$24.4K

Natco Pharma Limited ranks #6 among 171 Indian Apixaban exporters. Average shipment value of $50.0K compared to the market average of $497.1K. The closest competitors by value are MACLEODS PHARMACEUTICALS LTD and UNISON PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Apixaban Exports?

Port	Shipments	% Share
SAHAR AIR	724	16.1%
SAHAR AIR CARGO ACC (INBOM4)	674	15.0%
DELHI AIR CARGO ACC (INDEL4)	607	13.5%
DELHI AIR	364	8.1%
MUNDRA SEA	146	3.3%
Bombay Air	134	3.0%
JNPT/ NHAVA SHEVA SEA	131	2.9%
AHEMDABAD AIR ACC (INAMD4)	129	2.9%

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Apixaban Exports

Natco's export operations are currently navigating a complex geopolitical landscape. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. These challenges are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in logistics and supply chain management. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced additional complexities for Indian pharmaceutical exporters. The U.S. administration's imposition of tariffs on imports from various countries, including India, has raised concerns about the competitiveness of Indian generics in the U.S. market. These tariffs could potentially erode profit margins and affect pricing strategies. (apnews.com)

Conversely, the European Union's stringent regulatory changes, such as the Falsified Medicines Directive, have heightened compliance requirements for exporters. While these regulations aim to ensure product authenticity and safety, they also necessitate significant investments in serialization and traceability systems. For companies like Natco, adhering to these standards is crucial for maintaining access to the lucrative EU market.

Natco Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing intensified scrutiny regarding quality and compliance. The U.S. Food and Drug Administration (FDA) has increased inspections of Indian manufacturing facilities, emphasizing adherence to Good Manufacturing Practices (GMP). Non-compliance can lead to warning letters, import alerts, or even bans, posing significant risks to exporters. (fact.net.in)

Natco's commitment to quality is evident in its proactive measures to meet international standards. The company's recent product approvals and successful market entries suggest a robust compliance framework. However, continuous vigilance and investment in quality systems are imperative to navigate the evolving regulatory landscape and to sustain export growth.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Natco Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 72 individual customs records matching Natco Pharma Limited exporting Apixaban, covering 49 formulations to 7 countries via 15 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 371+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Apixaban

Apixaban

Natco Pharma Limited — Apixaban Exporter Profile

Natco Pharma Limited — Apixaban Export Profile: Buyers & Destinations

Where Does Natco Pharma Limited Export Apixaban?

Who Are the Top Buyers of Apixaban from Natco Pharma Limited?

What Is India's Total Apixaban Export Value and How Much Does Natco Pharma Limited Contribute?

What Is the Average Shipment Value for Natco Pharma Limited's Apixaban Exports?

How Does Natco Pharma Limited Compare to Other Indian Apixaban Exporters?

What Apixaban Formulations Does Natco Pharma Limited Export?

Regulatory Requirements: Exporting Apixaban to Key Markets

Brazil — ANVISA

Canada — HC

How Does Natco Pharma Limited Compare to Nearest Apixaban Exporters?

Which Indian Ports Ship Apixaban Exports?

What Other Cardiovascular Products Does Natco Pharma Limited Export?

Geopolitical & Trade Policy Impact on Natco Pharma Limited's Apixaban Exports

Natco Pharma Limited — Regulatory Compliance & Quality Standards

About Natco Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Apixaban Export Data from Natco Pharma Limited

Apixaban Stats

Company Overview

Top Products by Natco Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source